Anticancer Drugs Designed by Mother Nature: Ancient Drugs but Modern Targets
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3400-3416
Author(s):
Haruyo Ichikawa, Yutaka Nakamura, Yoshiki Kashiwada and Bharat B. Aggarwal
Novel Marine-Derived Anti-Cancer Agents
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3417-3426
Author(s):
Thomas E. Adrian
Contrast Enhanced Sonography for Diagnosis of (Peri-) Splenic Pathology
Journal:
Current Medical Imaging
Volume:
3
Page:
283-293
Author(s):
Christian Gorg and Till Bert
The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action
Journal:
Current Genomics
Volume:
8
Page:
453-465
Author(s):
M. J. Simmonds and S. C.L. Gough
Nutrition in Infancy
Journal:
Current Pediatric Reviews
Volume:
3
Page:
293-300
Author(s):
Hania Szajewska and Andrea Horvath
Voltage-Gated Ion Channels, New Targets in Anti-Cancer Research
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
189-202
Author(s):
Le Guennec Jean-Yves, Ouadid-Ahidouch Halima, Soriani Olivier, Besson Pierre, Ahidouch Ahmed and Vandier Christophe
Potassium Channels are a New Target Field in Anticancer Drug Design
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
212-223
Author(s):
Nuria Villalonga, Joan C. Ferrere, Josep M. Argiles, Enric Condom and Antonio Felipe
To Be, or Not To Be: That is the Question-Lineage Commitment in Hematopoiesis
Journal:
Current Immunology Reviews (Discontinued)
Volume:
3
Page:
258-268
Author(s):
Motonari Kondo and Chia-Lin Hsu
Targeting the Human Thioredoxin System by Diverse Strategies to Treat Cancer and Other Pathologies
Journal:
Recent Patents on DNA & Gene Sequences
Volume:
1
Page:
164-175
Author(s):
Kathryn F. Tonissen
Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
3020-3037
Author(s):
P. McCaffery and C. Simons